Wall Street analyst estimates for Cardio Diagnostics Holdings, Inc. (CDIO): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| Price / Book | 0.80 |
| EV / EBITDA | -0.05 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | $901 | $950 | $17065 | $34890 | $14825 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | $901 | $950 | $17065 | $34890 | $14825 |
| Research & Development | $1500 | $31468 | $40448 | $145182 | $227966 | $641212 |
| Selling, General & Admin | $596997 | $573881 | $4.5M | $7.1M | $8.2M | $5.8M |
| Operating Expenses | $609164 | $621349 | $4.5M | $7.3M | $8.4M | $6.5M |
| Operating Income | -$609164 | -$620448 | -$4.5M | -$7.2M | -$8.4M | -$6.5M |
| EBITDA | -$598497 | -$604448 | -$4.6M | -$1.5M | -$8.1M | -$6.1M |
| Interest Expense | 0 | 0 | 0 | $6.7M | $18640 | $14801 |
| Pre-tax Income | -$605164 | -$620448 | -$4.7M | -$8.4M | -$8.4M | -$6.5M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$605164 | -$620448 | -$4.7M | -$8.4M | -$8.4M | -$6.5M |
| EPS | $-0.06 | $-1.96 | $-45.30 | $-19.80 | $-9.30 | $-3.71 |
| EPS (Diluted) | $-0.06 | $-1.96 | $-45.30 | $-19.80 | $-9.30 | $-3.71 |
| Shares Outstanding (Diluted) | $9.5M | $317158 | $3.1M | $422837 | $26.9M | $1.8M |
Price
| Price | $2.00 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ADIL · ADXN · BCDA · BCLI · CELZ · IBO · MTNB
Explore sector: Healthcare · Biotechnology
More sections of CDIO: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks